Article(id=1330184503118639458, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2023.07.009, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1683648000000, receivedDateStr=2023-05-10, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795070299176, onlineDateStr=2026-11-19, pubDate=1688918400000, pubDateStr=2023-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795070299176, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795070299176, creator=13701087609, updateTime=1795070299176, updator=13701087609, issue=Issue{id=1330184417563226564, tenantId=1146029695717560320, journalId=1319690259887390882, year='2023', volume='54', issue='7', pageStart='983', pageEnd='1143', issueExtLink='null', onlineDate='null', pubDate='1688918400000', pubDateStr='2023-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795070278778, creator='13701087609', updateTime=1795080510554, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330227333488816580, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330227333488816581, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1330184417563226564, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1052, endPage=1059, ext={EN=ArticleExt(id=1330184504733446499, articleId=1330184503118639458, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Recent Advances in Antitumor Mechanism of Baicalein and Its Nano Delivery Systems, columnId=1327671134809600231, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Baicalein, a flavone derived from Scutellaria baicalensis, exhibits antitumor effect by suppressing tumor cell proliferation, inducing tumor cell apoptosis, inhibiting tumor angiogenesis, and regulating the tumor microenvironment. However, its poor solubility has attenuated the bioavailability and thus restricting the efficacy. Many studies utilize nano-drug delivery systems to improve bioavailability and antitumor efficacy of baicalein. This review summarizes the recent studies concerning the antitumor mechanisms of baicalein and its nano delivery systems to provide approaches for its further basic research and clinical application.

, authors=Linwei LU1, 2, Yuan DING2, Qianzhu XU2, Weiyue LU2, 3, *, authorsList=Linwei LU, Yuan DING, Qianzhu XU, Weiyue LU, authorCompany=null, correspAuthors=Weiyue LU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330184504930578788, articleId=1330184503118639458, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=黄芩素抗肿瘤机制及其纳米递送系统研究进展, columnId=1327671135019315436, journalTitle=中国医药工业杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

黄芩素是来源于中药黄芩的一种黄酮类成分,能通过抑制肿瘤细胞生长、诱导肿瘤细胞凋亡、抑制肿瘤血管生成、调节肿瘤微环境等多种途径发挥抗肿瘤作用。然而,其溶解度不高,影响了体内生物利用度和药效。因此,许多研究采用丰富多样的纳米递送策略帮助改善其生物利用度以提升抗肿瘤药效。该文总结了黄芩素抗肿瘤机制及其纳米递送系统,以期为黄芩素的基础研究及临床应用提供参考。

, authors=陆林玮1, 2, 丁源2, 许倩竹2, 陆伟跃2, 3, *, authorsList=陆林玮, 丁源, 许倩竹, 陆伟跃, authorCompany=null, correspAuthors=陆伟跃, authorNote=

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

, correspAuthorsNote=
陆伟跃(1960—),男,博士,复旦大学药学院教授、博士生导师,从事药物靶向策略及递药系统研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=Zg+0/boPHU7LoQfNeAO/OA==, magXml=f1aYaQGlCCTKF6dGMwlfYQ==, pdfUrl=null, pdf=tUycEanSFrwN++XZ/lpsiA==, pdfFileSize=1544016, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=DPkJ6iSgRYX3Vl/EO0i6JA==, mapNumber=null, fund=null)}, authors=[Author(id=1330184505366786415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505442283890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505366786415, language=EN, stringName=Linwei LU, firstName=Linwei, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040
2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184505501004147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505366786415, language=CN, stringName=陆林玮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属华山医院中西医结合科,上海 200040
2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio={"content":"

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

"}, bioImg=null, bioContent=

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505144488293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=1., ext=[AuthorCompanyExt(id=1330184505152876902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040), AuthorCompanyExt(id=1330184505161265511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属华山医院中西医结合科,上海 200040)]), AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184505597473141, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505761050999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505597473141, language=EN, stringName=Yuan DING, firstName=Yuan, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184505828159864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505597473141, language=CN, stringName=丁源, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184505895268730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505974960508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505895268730, language=EN, stringName=Qianzhu XU, firstName=Qianzhu, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184506025292157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505895268730, language=CN, stringName=许倩竹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184506079818111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wylu@shmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184506159509890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184506079818111, language=EN, stringName=Weiyue LU, firstName=Weiyue, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203
3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184506218230147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184506079818111, language=CN, stringName=陆伟跃, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203
3.上海泰禛生物技术有限公司研发部,上海 201314, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)]), AuthorCompany(id=1330184505291288939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=3., ext=[AuthorCompanyExt(id=1330184505299677548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314), AuthorCompanyExt(id=1330184505308066157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海泰禛生物技术有限公司研发部,上海 201314)])])], keywords=[Keyword(id=1330184506314699140, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=EN, orderNo=1, keyword=baicalein), Keyword(id=1330184506373419397, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=EN, orderNo=2, keyword=antitumor mechanism), Keyword(id=1330184506444722566, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=EN, orderNo=3, keyword=bioavailability), Keyword(id=1330184506507637127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=EN, orderNo=4, keyword=nano-drug delivery system), Keyword(id=1330184506574745992, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=EN, orderNo=5, keyword=tumor treatment), Keyword(id=1330184506646049161, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=CN, orderNo=1, keyword=黄芩素), Keyword(id=1330184506708963722, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=CN, orderNo=2, keyword=抗肿瘤机制), Keyword(id=1330184506780266891, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=CN, orderNo=3, keyword=生物利用度), Keyword(id=1330184506859958668, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=CN, orderNo=4, keyword=纳米递药系统), Keyword(id=1330184506931261837, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, language=CN, orderNo=5, keyword=肿瘤治疗)], refs=[Reference(id=1330184507178725776, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249., articleTitle=null, refAbstract=null), Reference(id=1330184507237446033, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69., articleTitle=null, refAbstract=null), Reference(id=1330184507300360594, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=牛春超,张立德,黄晶晶.中药抗肿瘤作用机制研究进展[J].辽宁中医药大学学报,2023,25(3):132-136., articleTitle=null, refAbstract=null), Reference(id=1330184507367469459, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=LU L W, DONG J C, GONG W Y. Advances in basic research of traditional Chinese medicine herbal formulae in the treatment of non-small cell lung cancer [J]. Tradit Med Mod Med, 2022, 4(1): 1-11., articleTitle=null, refAbstract=null), Reference(id=1330184507442966932, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG W Y, ZHAO Z X, LIU B J, et al. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors [J]. Eur J Med Chem,2017, 126: 844-852., articleTitle=null, refAbstract=null), Reference(id=1330184507518464405, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=邱爽,牟佳佳,邓雁如.黄芩素的结构修饰及其药理活性研究进展[J].中国药物化学杂志,2021,31(5):390-399., articleTitle=null, refAbstract=null), Reference(id=1330184509129077144, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=YU G, CHEN L Z, HU Y H, et al. Antitumor effects of baicalein and its mechanism via TGFβ pathway in cervical cancer HeLa cells [J]. Evid Based Complement Alternat Med, 2021, 2021: 5527190., articleTitle=null, refAbstract=null), Reference(id=1330184509242323353, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=QIAO D, JIN J, XING J, et al. Baicalein inhibits gastric cancer cell proliferation and migration through a FAK interaction via AKT/mTOR signaling [J]. Am J Chin Med,2021, 49(2): 525-541., articleTitle=null, refAbstract=null), Reference(id=1330184509313626522, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO Z X, HU X L, XING Z Q, et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway [J]. Mol Cell Biochem, 2015,406(1/2): 111-119., articleTitle=null, refAbstract=null), Reference(id=1330184509376541083, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=HU J, WANG R, LIU Y, et al. Baicalein represses cervical cancer cell growth, cell cycle progression and promotes apoptosis via blocking AKT/mTOR pathway by the regulation of circHIAT1/miR-19a-3p axis [J]. Onco Targets Ther, 2021, 14: 905-916., articleTitle=null, refAbstract=null), Reference(id=1330184509439455644, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=YU X L, YANG Y C, LI Y, et al. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway [J]. Int J Biochem Cell Biol, 2018, 94: 107-118., articleTitle=null, refAbstract=null), Reference(id=1330184509502370205, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Z X, LIU B J, SUN J, et al. Scutellaria flavonoids effectively inhibit the malignant phenotypes of non-small cell lung cancer in an Id1-dependent manner [J]. Int J Biol Sci,2019, 15(7): 1500-1513., articleTitle=null, refAbstract=null), Reference(id=1330184509577867678, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHAO Z X, LIU B J, SUN J, et al. Baicalein inhibits orthotopic human non-small cell lung cancer xenografts via Src/Id1 pathway [J]. Evid Based Complement Alternat Med, 2019, 2019: 9806062., articleTitle=null, refAbstract=null), Reference(id=1330184509644976543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GU L, XU F, ZHANG X L, et al. Baicalein inhibits the SMYD2/RPS7 signaling pathway to inhibit the occurrence and metastasis of lung cancer [J]. J Oncol, 2022, 2022:3796218., articleTitle=null, refAbstract=null), Reference(id=1330184509724668320, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=YU X L, CAO Y, TANG L, et al. Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8-AS1-N [J]. J Cell Biochem, 2018,119(8): 6842-6856., articleTitle=null, refAbstract=null), Reference(id=1330184509791777185, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=SONG L B, CHEN X Y, WANG P, et al. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway [J]. Acta Biochim Biophys Sin(Shanghai), 2018, 50(6): 586-596., articleTitle=null, refAbstract=null), Reference(id=1330184509863080354, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=MU J S, LIU T R, JIANG L, et al. The traditional Chinese medicine baicalein potently inhibits gastric cancer cells [J]. J Cancer, 2016, 7(4): 453-461., articleTitle=null, refAbstract=null), Reference(id=1330184509934383523, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=YAN W J, MA X C, ZHAO X Y, et al. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and in vitro [J]. Drug Des Devel Ther, 2018, 12: 3961-3972., articleTitle=null, refAbstract=null), Reference(id=1330184510001492388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=YU X L, LIU Y Q, WANG Y Z, et al. Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway [J]. Mol Med Rep, 2018, 17(4): 5088-5094., articleTitle=null, refAbstract=null), Reference(id=1330184510076989861, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=GAO Z L, ZHANG Y Q, ZHOU H, et al. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1[J]. Int J Oncol, 2020, 56(1): 273-282., articleTitle=null, refAbstract=null), Reference(id=1330184510160875942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=DENG X H, LIU J J, LIU L T, et al. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway [J]. Int J Biol Sci, 2020, 16(8):1403-1416., articleTitle=null, refAbstract=null), Reference(id=1330184510223790503, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=MA D H, CHEN S N, WANG H M, et al. Baicalein induces apoptosis of pancreatic cancer cells by regulating the expression of miR-139-3p and miR-196b-5p [J]. Front Oncol, 2021, 11: 653061., articleTitle=null, refAbstract=null), Reference(id=1330184510303482280, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=CATHCART M C, USECKAITE Z, DRAKEFORD C, et al. Anti-cancer effects of baicalein in non-small cell lung cancer in vitro and in vivo [J]. BMC Cancer, 2016, 16:707., articleTitle=null, refAbstract=null), Reference(id=1330184510374785449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN M T, ZHONG K Y, TAN J C, et al. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1alpha/VEGF signaling pathway in colorectal cancer[J]. Clin Transl Med, 2021, 11(11): e564., articleTitle=null, refAbstract=null), Reference(id=1330184510441894314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Z, NONG L, CHEN M L, et al. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line [J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(9): 1007-1015., articleTitle=null, refAbstract=null), Reference(id=1330184510504808875, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=DANI S G, KIHO M, KEISUKE O, et al. Anti-metastatic effects of baicalein by targeting STAT3 activity in breast cancer cells [J]. Biol Pharm Bull, 2020, 43(12): 1899-1905., articleTitle=null, refAbstract=null), Reference(id=1330184510567723436, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG X L, RUAN Q L, ZHAI Y Q, et al. Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment[J]. Cancer Sci, 2020, 111(10): 3802-3812., articleTitle=null, refAbstract=null), Reference(id=1330184510639026605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=HE S, WANG S S, LIU S Q, et al. Baicalein potentiated M1 macrophage polarization in cancer through targeting PI3Kγ/NF-κB signaling [J]. Front Pharmacol, 2021, 12: 743837., articleTitle=null, refAbstract=null), Reference(id=1330184510706135470, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=LI P, HU J R, SHI B Z, et al. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway[J]. Biochem Biophys Res Commun, 2020, 531(3): 320-327., articleTitle=null, refAbstract=null), Reference(id=1330184510760661423, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=YU M L, QI B Q, W X X , et al. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway [J]. Biomed Pharmacother,2017, 90: 677-685., articleTitle=null, refAbstract=null), Reference(id=1330184510819381680, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=LU L W, ZHANG M F, WANG X Y, et al. Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a beta-catenin-dependent manner [J]. Phytother Res, 2020, 34(1): 104-117., articleTitle=null, refAbstract=null), Reference(id=1330184510890684849, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN Y, ZHANG J Y, ZHANG M Q, et al. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α[J]. Clin Transl Med, 2021, 11(11): e577., articleTitle=null, refAbstract=null), Reference(id=1330184510953599410, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=HE K, YU X L, WANG X Y, et al. Baicalein and Ly294002 induces liver cancer cells apoptosis via regulating phosphatidyl inositol 3-kinase/Akt signaling pathway [J]. J Cancer Res Ther, 2018, 14(Suppl): S519-S525., articleTitle=null, refAbstract=null), Reference(id=1330184511020708275, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=KUO Y T, LIU C H, WONG S H, et al. Small molecules baicalein and cinnamaldehyde are potentiators of measles virus-induced breast cancer oncolysis [J]. Phytomedicine,2021, 89: 153611., articleTitle=null, refAbstract=null), Reference(id=1330184511112982964, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MARKOWSKI A, ZAREMBA-CZOGALLA M, JAROMIN A, et al. Novel liposomal formulation of baicalein for the treatment of pancreatic ductal adenocarcinoma: design, characterization, and evaluation [J]. Pharmaceutics, 2023,15(1): 179., articleTitle=null, refAbstract=null), Reference(id=1330184511180091829, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=LIANG J, WU W L, LIU Q W, et al. Long-circulating nanoliposomes(LCNs) sustained delivery of baicalein(BAI) with desired oral bioavailability in vivo [J]. Drug Deliv,2013, 20(8): 319-323., articleTitle=null, refAbstract=null), Reference(id=1330184511238812086, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=LI K, ZHANG H, GAO L, et al. Preparation and characterization of baicalein-loaded nanoliposomes for antitumor therapy [J]. J Nanomater, 2016, 2016(12):1-9., articleTitle=null, refAbstract=null), Reference(id=1330184511322698167, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=栗达,贾颜鸿,周童,等.固体脂质纳米粒药物载体在肿瘤治疗中应用的研究进展[J].吉林大学学报(医学版),2020,46(1):200-204., articleTitle=null, refAbstract=null), Reference(id=1330184511381418424, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=JOSHI H A, PATWARDHAN R S, SHARMA D, et al. Pre-clinical evaluation of an innovative oral nano-formulation of baicalein for modulation of radiation responses [J]. Int J Pharm, 2021, 595: 120181., articleTitle=null, refAbstract=null), Reference(id=1330184511452721593, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=LI S, WANG L, LI N, et al. Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin[J]. Biomed Pharmacother, 2017, 95: 548-555., articleTitle=null, refAbstract=null), Reference(id=1330184511507247546, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=陈梦雨,王慧楠,王佩华,等.纳米结构脂质载体在抗肿瘤中药单体活性成分中的研究进展[J].中华中医药杂志,2021,36(12):7227-7229., articleTitle=null, refAbstract=null), Reference(id=1330184511565967803, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Q, LI J, PU G B, et al. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy [J]. Drug Deliv,2016, 23(4): 1364-1368., articleTitle=null, refAbstract=null), Reference(id=1330184511628882364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=LU Z H, SU J R, LI Z R, et al. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy [J]. Drug Dev Ind Pharm, 2017,43(1): 160-170., articleTitle=null, refAbstract=null), Reference(id=1330184511683408317, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=DHAVAL M, VAGHELA P, PATEL K, et al. Lipid-based emulsion drug delivery systems - a comprehensive review[J]. Drug Deliv Transl Res, 2022, 12(7): 1616-1639., articleTitle=null, refAbstract=null), Reference(id=1330184511763100094, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=YIN J T, XIANG C Y, WANG P P, et al. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability [J]. Int J Nanomedicine, 2017, 12: 2923-2931., articleTitle=null, refAbstract=null), Reference(id=1330184511826014655, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=SRIVASTAVA S, SINGH S, SARAF S A, et al. Encapsulation of baicalein in cinnamon essential oil nanoemulsion for enhanced anticancer efficacy against MDA-MB-231 cells [J]. BioNanoSci, 2021, 11(6): 1049-1060., articleTitle=null, refAbstract=null), Reference(id=1330184511893123520, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=MENG L H, XIA X J, YANG Y F, et al. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition [J]. Int J Pharm, 2016, 513(1/2):8-16., articleTitle=null, refAbstract=null), Reference(id=1330184511964426689, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU W L, TIAN R, HU W J, et al. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein [J]. Fitoterapia, 2012, 83(8): 1532-1539., articleTitle=null, refAbstract=null), Reference(id=1330184513570845122, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=LIAO H F, GAO Y, LIAN C F, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems [J]. Int J Nanomedicine, 2019, 14: 7291-7306., articleTitle=null, refAbstract=null), Reference(id=1330184513696674243, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=SHEN H, LIU Y, ZHANG H, et al. Enhancing the oral bioavailability of baicalein via Solutol® HS15 and Poloxamer 188 mixed micelles system [J]. J Pharm Pharmacol, 2019,71(5): 765-773., articleTitle=null, refAbstract=null), Reference(id=1330184513780560324, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=SRIVASTAVA S, KUMAR A, YADAV P K, et al. Formulation and performance evaluation of polymeric mixed micelles encapsulated with baicalein for breast cancer treatment [J]. Drug Dev Ind Pharm, 2021, 47(9): 1512-1522., articleTitle=null, refAbstract=null), Reference(id=1330184513839280581, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=NIPUN BABU V, KANNAN S. Enhanced delivery of baicalein using cinnamaldehyde cross-linked chitosan nanoparticle inducing apoptosis [J]. Int J Biol Macromol,2012, 51(5): 1103-1108., articleTitle=null, refAbstract=null), Reference(id=1330184513910583750, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHENG F, LUO Y J, LIU Y Q, et al. Nano-baicalein facilitates chemotherapy in breast cancer by targeting tumor microenvironment [J]. Int J Pharm, 2023, 635: 122778., articleTitle=null, refAbstract=null), Reference(id=1330184513981886919, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG W, XI M, DUAN X Z, et al. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo [J]. Int J Nanomedicine,2015, 10: 3737-3750., articleTitle=null, refAbstract=null), Reference(id=1330184514048995784, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU Z D, HU C L, LIU S N, et al. Facile synthesis of Fe-baicalein nanoparticles for photothermal/chemodynamic therapy with accelerated FeⅢ/FeⅡ conversion [J]. J Mater Chem B, 2021, 9(15): 3295-3299., articleTitle=null, refAbstract=null), Reference(id=1330184514132881865, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=null, journalName=null, refType=null, unstructuredReference=LU L W, XU Q Z, WANG J, et al. Drug nanocrystals for active tumor-targeted drug delivery [J]. Pharmaceutics,2022, 14(4): 797., articleTitle=null, refAbstract=null), Reference(id=1330184514191602122, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG J J, LV H X, JIANG K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal [J]. Int J Pharm, 2011, 420(1): 180-188., articleTitle=null, refAbstract=null), Reference(id=1330184514258710987, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=null, journalName=null, refType=null, unstructuredReference=GUO M S, SUN X J, CHEN J H, et al. Pharmaceutical cocrystals: a review of preparations, physicochemical properties and applications [J]. Acta Pharm Sin B, 2021,11(8): 2537-2564., articleTitle=null, refAbstract=null), Reference(id=1330184514346791372, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=null, journalName=null, refType=null, unstructuredReference=PI J X, WANG S Y, LI W, et al. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein [J]. Asian J Pharm Sci, 2019, 14(2): 154-164., articleTitle=null, refAbstract=null), Reference(id=1330184514413900237, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=null, journalName=null, refType=null, unstructuredReference=DING M L, LIU W B, GREF R. Nanoscale MOFs: from synthesis to drug delivery and theranostics applications [J]. Adv Drug Deliv Rev, 2022, 190: 114496., articleTitle=null, refAbstract=null), Reference(id=1330184514481009102, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=null, journalName=null, refType=null, unstructuredReference=时慧,汪河滨,连培涵,等.ZIF-8纳米载体的制备及负载黄芩素性能研究[J].塔里木大学学报,2021,33(4):29-35., articleTitle=null, refAbstract=null), Reference(id=1330184514573283791, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[62], rfOrder=61, authorNames=null, journalName=null, refType=null, unstructuredReference=邬思豪,陈江波,刘为营,等.沸石咪唑类骨架负载黄芩素纳米材料的构建及释药研究[J].天津理工大学学报,2022,38(3):59-64., articleTitle=null, refAbstract=null)], funds=[Fund(id=1330184507015147918, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, awardId=20YF1404500, language=CN, fundingSource=上海市青年科技英才扬帆计划(20YF1404500), fundOrder=null, country=null), Fund(id=1330184507090645391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, awardId=2019QD012, language=CN, fundingSource=复旦大学附属华山医院科研启动基金项目(2019QD012), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1330184505144488293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=1., ext=[AuthorCompanyExt(id=1330184505152876902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040), AuthorCompanyExt(id=1330184505161265511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属华山医院中西医结合科,上海 200040)]), AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)]), AuthorCompany(id=1330184505291288939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=3., ext=[AuthorCompanyExt(id=1330184505299677548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314), AuthorCompanyExt(id=1330184505308066157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海泰禛生物技术有限公司研发部,上海 201314)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.009, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2023.07.009, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2023.07.009, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2023.07.009, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1688918400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
黄芩素抗肿瘤机制及其纳米递送系统研究进展
陆林玮 1, 2 , 丁源 2 , 许倩竹 2 , 陆伟跃 2, 3, *
中国医药工业杂志 | 综述 2023,54(7): 1052-1059
收起
收藏切换
中国医药工业杂志 |综述 2023 , 54 (7) : 1052 -1059
黄芩素抗肿瘤机制及其纳米递送系统研究进展
全屏
[Author(id=1330184505366786415, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505442283890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505366786415, language=EN, stringName=Linwei LU, firstName=Linwei, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040
2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184505501004147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505366786415, language=CN, stringName=陆林玮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.复旦大学附属华山医院中西医结合科,上海 200040
2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio={"content":"

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

"}, bioImg=null, bioContent=

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505144488293, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=1., ext=[AuthorCompanyExt(id=1330184505152876902, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040), AuthorCompanyExt(id=1330184505161265511, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505144488293, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属华山医院中西医结合科,上海 200040)]), AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184505597473141, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505761050999, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505597473141, language=EN, stringName=Yuan DING, firstName=Yuan, middleName=null, lastName=DING, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184505828159864, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505597473141, language=CN, stringName=丁源, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184505895268730, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330184505974960508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505895268730, language=EN, stringName=Qianzhu XU, firstName=Qianzhu, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184506025292157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184505895268730, language=CN, stringName=许倩竹, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)])]), Author(id=1330184506079818111, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=wylu@shmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330184506159509890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184506079818111, language=EN, stringName=Weiyue LU, firstName=Weiyue, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203
3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330184506218230147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, authorId=1330184506079818111, language=CN, stringName=陆伟跃, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, 3, *, address=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203
3.上海泰禛生物技术有限公司研发部,上海 201314, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330184505215791464, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=2., ext=[AuthorCompanyExt(id=1330184505224180073, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203), AuthorCompanyExt(id=1330184505232568682, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505215791464, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203)]), AuthorCompany(id=1330184505291288939, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, xref=3., ext=[AuthorCompanyExt(id=1330184505299677548, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314), AuthorCompanyExt(id=1330184505308066157, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1330184503118639458, companyId=1330184505291288939, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.上海泰禛生物技术有限公司研发部,上海 201314)])])]
陆林玮1, 2, 丁源2, 许倩竹2, 陆伟跃2, 3, *
作者信息
  • 1.复旦大学附属华山医院中西医结合科,上海 200040
  • 2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203
  • 3.上海泰禛生物技术有限公司研发部,上海 201314
通讯作者:
陆伟跃(1960—),男,博士,复旦大学药学院教授、博士生导师,从事药物靶向策略及递药系统研究。E-mail:
作者简介:

陆林玮(1990—),女,中西医结合临床博士,复旦大学附属华山医院中西医结合科助理研究员,从事中药有效成分及中西药物结合抗肿瘤、药物靶向递送抗肿瘤研究。

Recent Advances in Antitumor Mechanism of Baicalein and Its Nano Delivery Systems
Linwei LU1, 2, Yuan DING2, Qianzhu XU2, Weiyue LU2, 3, *
Affiliations
  • 1.Dept. of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040
  • 2.Key Lab. of Smart Drug Delivery (Fudan University), Ministry of Education and PLA, Dept. of Pharmaceutics, School of Pharmacy, Fudan University & Institutes of Integrative Medicine, Fudan University, Shanghai 201203
  • 3.Dept. of Research and Development, Shanghai Tayzen PharmLab Co., Ltd., Shanghai 201314
出版时间: 2023-07-10 doi: 10.16522/j.cnki.cjph.2023.07.009
文章导航
收藏切换

黄芩素是来源于中药黄芩的一种黄酮类成分,能通过抑制肿瘤细胞生长、诱导肿瘤细胞凋亡、抑制肿瘤血管生成、调节肿瘤微环境等多种途径发挥抗肿瘤作用。然而,其溶解度不高,影响了体内生物利用度和药效。因此,许多研究采用丰富多样的纳米递送策略帮助改善其生物利用度以提升抗肿瘤药效。该文总结了黄芩素抗肿瘤机制及其纳米递送系统,以期为黄芩素的基础研究及临床应用提供参考。

黄芩素  /  抗肿瘤机制  /  生物利用度  /  纳米递药系统  /  肿瘤治疗

Baicalein, a flavone derived from Scutellaria baicalensis, exhibits antitumor effect by suppressing tumor cell proliferation, inducing tumor cell apoptosis, inhibiting tumor angiogenesis, and regulating the tumor microenvironment. However, its poor solubility has attenuated the bioavailability and thus restricting the efficacy. Many studies utilize nano-drug delivery systems to improve bioavailability and antitumor efficacy of baicalein. This review summarizes the recent studies concerning the antitumor mechanisms of baicalein and its nano delivery systems to provide approaches for its further basic research and clinical application.

baicalein  /  antitumor mechanism  /  bioavailability  /  nano-drug delivery system  /  tumor treatment
陆林玮, 丁源, 许倩竹, 陆伟跃. 黄芩素抗肿瘤机制及其纳米递送系统研究进展. 中国医药工业杂志, 2023 , 54 (7) : 1052 -1059 . DOI: 10.16522/j.cnki.cjph.2023.07.009
Linwei LU, Yuan DING, Qianzhu XU, Weiyue LU. Recent Advances in Antitumor Mechanism of Baicalein and Its Nano Delivery Systems[J]. Chinese Journal of Pharmaceuticals, 2023 , 54 (7) : 1052 -1059 . DOI: 10.16522/j.cnki.cjph.2023.07.009
  • 上海市青年科技英才扬帆计划(20YF1404500)
  • 复旦大学附属华山医院科研启动基金项目(2019QD012)
参考文献 引证文献
排序方式:
[1]
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[2]
曹毛毛,陈万青.GLOBOCAN 2020全球癌症统计数据解读[J].中国医学前沿杂志(电子版),2021,13(3):63-69.
[3]
牛春超,张立德,黄晶晶.中药抗肿瘤作用机制研究进展[J].辽宁中医药大学学报,2023,25(3):132-136.
[4]
LU L W, DONG J C, GONG W Y. Advances in basic research of traditional Chinese medicine herbal formulae in the treatment of non-small cell lung cancer [J]. Tradit Med Mod Med, 2022, 4(1): 1-11.
[5]
GONG W Y, ZHAO Z X, LIU B J, et al. Exploring the chemopreventive properties and perspectives of baicalin and its aglycone baicalein in solid tumors [J]. Eur J Med Chem,2017, 126: 844-852.
[6]
邱爽,牟佳佳,邓雁如.黄芩素的结构修饰及其药理活性研究进展[J].中国药物化学杂志,2021,31(5):390-399.
[7]
YU G, CHEN L Z, HU Y H, et al. Antitumor effects of baicalein and its mechanism via TGFβ pathway in cervical cancer HeLa cells [J]. Evid Based Complement Alternat Med, 2021, 2021: 5527190.
[8]
QIAO D, JIN J, XING J, et al. Baicalein inhibits gastric cancer cell proliferation and migration through a FAK interaction via AKT/mTOR signaling [J]. Am J Chin Med,2021, 49(2): 525-541.
[9]
GUO Z X, HU X L, XING Z Q, et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway [J]. Mol Cell Biochem, 2015,406(1/2): 111-119.
[10]
HU J, WANG R, LIU Y, et al. Baicalein represses cervical cancer cell growth, cell cycle progression and promotes apoptosis via blocking AKT/mTOR pathway by the regulation of circHIAT1/miR-19a-3p axis [J]. Onco Targets Ther, 2021, 14: 905-916.
[11]
YU X L, YANG Y C, LI Y, et al. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway [J]. Int J Biochem Cell Biol, 2018, 94: 107-118.
[12]
ZHAO Z X, LIU B J, SUN J, et al. Scutellaria flavonoids effectively inhibit the malignant phenotypes of non-small cell lung cancer in an Id1-dependent manner [J]. Int J Biol Sci,2019, 15(7): 1500-1513.
[13]
ZHAO Z X, LIU B J, SUN J, et al. Baicalein inhibits orthotopic human non-small cell lung cancer xenografts via Src/Id1 pathway [J]. Evid Based Complement Alternat Med, 2019, 2019: 9806062.
[14]
GU L, XU F, ZHANG X L, et al. Baicalein inhibits the SMYD2/RPS7 signaling pathway to inhibit the occurrence and metastasis of lung cancer [J]. J Oncol, 2022, 2022:3796218.
[15]
YU X L, CAO Y, TANG L, et al. Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8-AS1-N [J]. J Cell Biochem, 2018,119(8): 6842-6856.
[16]
SONG L B, CHEN X Y, WANG P, et al. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway [J]. Acta Biochim Biophys Sin(Shanghai), 2018, 50(6): 586-596.
[17]
MU J S, LIU T R, JIANG L, et al. The traditional Chinese medicine baicalein potently inhibits gastric cancer cells [J]. J Cancer, 2016, 7(4): 453-461.
[18]
YAN W J, MA X C, ZHAO X Y, et al. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and in vitro [J]. Drug Des Devel Ther, 2018, 12: 3961-3972.
[19]
YU X L, LIU Y Q, WANG Y Z, et al. Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway [J]. Mol Med Rep, 2018, 17(4): 5088-5094.
[20]
GAO Z L, ZHANG Y Q, ZHOU H, et al. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1[J]. Int J Oncol, 2020, 56(1): 273-282.
[21]
DENG X H, LIU J J, LIU L T, et al. Drp1-mediated mitochondrial fission contributes to baicalein-induced apoptosis and autophagy in lung cancer via activation of AMPK signaling pathway [J]. Int J Biol Sci, 2020, 16(8):1403-1416.
[22]
MA D H, CHEN S N, WANG H M, et al. Baicalein induces apoptosis of pancreatic cancer cells by regulating the expression of miR-139-3p and miR-196b-5p [J]. Front Oncol, 2021, 11: 653061.
[23]
CATHCART M C, USECKAITE Z, DRAKEFORD C, et al. Anti-cancer effects of baicalein in non-small cell lung cancer in vitro and in vivo [J]. BMC Cancer, 2016, 16:707.
[24]
CHEN M T, ZHONG K Y, TAN J C, et al. Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1alpha/VEGF signaling pathway in colorectal cancer[J]. Clin Transl Med, 2021, 11(11): e564.
[25]
ZHANG Z, NONG L, CHEN M L, et al. Baicalein suppresses vasculogenic mimicry through inhibiting RhoA/ROCK expression in lung cancer A549 cell line [J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52(9): 1007-1015.
[26]
DANI S G, KIHO M, KEISUKE O, et al. Anti-metastatic effects of baicalein by targeting STAT3 activity in breast cancer cells [J]. Biol Pharm Bull, 2020, 43(12): 1899-1905.
[27]
ZHANG X L, RUAN Q L, ZHAI Y Q, et al. Baicalein inhibits non-small-cell lung cancer invasion and metastasis by reducing ezrin tension in inflammation microenvironment[J]. Cancer Sci, 2020, 111(10): 3802-3812.
[28]
HE S, WANG S S, LIU S Q, et al. Baicalein potentiated M1 macrophage polarization in cancer through targeting PI3Kγ/NF-κB signaling [J]. Front Pharmacol, 2021, 12: 743837.
[29]
LI P, HU J R, SHI B Z, et al. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway[J]. Biochem Biophys Res Commun, 2020, 531(3): 320-327.
[30]
YU M L, QI B Q, W X X , et al. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway [J]. Biomed Pharmacother,2017, 90: 677-685.
[31]
LU L W, ZHANG M F, WANG X Y, et al. Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a beta-catenin-dependent manner [J]. Phytother Res, 2020, 34(1): 104-117.
[32]
CHEN Y, ZHANG J Y, ZHANG M Q, et al. Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1α[J]. Clin Transl Med, 2021, 11(11): e577.
[33]
HE K, YU X L, WANG X Y, et al. Baicalein and Ly294002 induces liver cancer cells apoptosis via regulating phosphatidyl inositol 3-kinase/Akt signaling pathway [J]. J Cancer Res Ther, 2018, 14(Suppl): S519-S525.
[34]
KUO Y T, LIU C H, WONG S H, et al. Small molecules baicalein and cinnamaldehyde are potentiators of measles virus-induced breast cancer oncolysis [J]. Phytomedicine,2021, 89: 153611.
[35]
MARKOWSKI A, ZAREMBA-CZOGALLA M, JAROMIN A, et al. Novel liposomal formulation of baicalein for the treatment of pancreatic ductal adenocarcinoma: design, characterization, and evaluation [J]. Pharmaceutics, 2023,15(1): 179.
[36]
LIANG J, WU W L, LIU Q W, et al. Long-circulating nanoliposomes(LCNs) sustained delivery of baicalein(BAI) with desired oral bioavailability in vivo [J]. Drug Deliv,2013, 20(8): 319-323.
[37]
LI K, ZHANG H, GAO L, et al. Preparation and characterization of baicalein-loaded nanoliposomes for antitumor therapy [J]. J Nanomater, 2016, 2016(12):1-9.
[38]
栗达,贾颜鸿,周童,等.固体脂质纳米粒药物载体在肿瘤治疗中应用的研究进展[J].吉林大学学报(医学版),2020,46(1):200-204.
[39]
JOSHI H A, PATWARDHAN R S, SHARMA D, et al. Pre-clinical evaluation of an innovative oral nano-formulation of baicalein for modulation of radiation responses [J]. Int J Pharm, 2021, 595: 120181.
[40]
LI S, WANG L, LI N, et al. Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin[J]. Biomed Pharmacother, 2017, 95: 548-555.
[41]
陈梦雨,王慧楠,王佩华,等.纳米结构脂质载体在抗肿瘤中药单体活性成分中的研究进展[J].中华中医药杂志,2021,36(12):7227-7229.
[42]
LIU Q, LI J, PU G B, et al. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy [J]. Drug Deliv,2016, 23(4): 1364-1368.
[43]
LU Z H, SU J R, LI Z R, et al. Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy [J]. Drug Dev Ind Pharm, 2017,43(1): 160-170.
[44]
DHAVAL M, VAGHELA P, PATEL K, et al. Lipid-based emulsion drug delivery systems - a comprehensive review[J]. Drug Deliv Transl Res, 2022, 12(7): 1616-1639.
[45]
YIN J T, XIANG C Y, WANG P P, et al. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability [J]. Int J Nanomedicine, 2017, 12: 2923-2931.
[46]
SRIVASTAVA S, SINGH S, SARAF S A, et al. Encapsulation of baicalein in cinnamon essential oil nanoemulsion for enhanced anticancer efficacy against MDA-MB-231 cells [J]. BioNanoSci, 2021, 11(6): 1049-1060.
[47]
MENG L H, XIA X J, YANG Y F, et al. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition [J]. Int J Pharm, 2016, 513(1/2):8-16.
[48]
LIU W L, TIAN R, HU W J, et al. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein [J]. Fitoterapia, 2012, 83(8): 1532-1539.
[49]
LIAO H F, GAO Y, LIAN C F, et al. Oral absorption and lymphatic transport of baicalein following drug-phospholipid complex incorporation in self-microemulsifying drug delivery systems [J]. Int J Nanomedicine, 2019, 14: 7291-7306.
[50]
SHEN H, LIU Y, ZHANG H, et al. Enhancing the oral bioavailability of baicalein via Solutol® HS15 and Poloxamer 188 mixed micelles system [J]. J Pharm Pharmacol, 2019,71(5): 765-773.
[51]
SRIVASTAVA S, KUMAR A, YADAV P K, et al. Formulation and performance evaluation of polymeric mixed micelles encapsulated with baicalein for breast cancer treatment [J]. Drug Dev Ind Pharm, 2021, 47(9): 1512-1522.
[52]
NIPUN BABU V, KANNAN S. Enhanced delivery of baicalein using cinnamaldehyde cross-linked chitosan nanoparticle inducing apoptosis [J]. Int J Biol Macromol,2012, 51(5): 1103-1108.
[53]
ZHENG F, LUO Y J, LIU Y Q, et al. Nano-baicalein facilitates chemotherapy in breast cancer by targeting tumor microenvironment [J]. Int J Pharm, 2023, 635: 122778.
[54]
WANG W, XI M, DUAN X Z, et al. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo [J]. Int J Nanomedicine,2015, 10: 3737-3750.
[55]
LIU Z D, HU C L, LIU S N, et al. Facile synthesis of Fe-baicalein nanoparticles for photothermal/chemodynamic therapy with accelerated FeⅢ/FeⅡ conversion [J]. J Mater Chem B, 2021, 9(15): 3295-3299.
[56]
LU L W, XU Q Z, WANG J, et al. Drug nanocrystals for active tumor-targeted drug delivery [J]. Pharmaceutics,2022, 14(4): 797.
[57]
ZHANG J J, LV H X, JIANG K, et al. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal [J]. Int J Pharm, 2011, 420(1): 180-188.
[58]
GUO M S, SUN X J, CHEN J H, et al. Pharmaceutical cocrystals: a review of preparations, physicochemical properties and applications [J]. Acta Pharm Sin B, 2021,11(8): 2537-2564.
[59]
PI J X, WANG S Y, LI W, et al. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein [J]. Asian J Pharm Sci, 2019, 14(2): 154-164.
[60]
DING M L, LIU W B, GREF R. Nanoscale MOFs: from synthesis to drug delivery and theranostics applications [J]. Adv Drug Deliv Rev, 2022, 190: 114496.
[61]
时慧,汪河滨,连培涵,等.ZIF-8纳米载体的制备及负载黄芩素性能研究[J].塔里木大学学报,2021,33(4):29-35.
[62]
邬思豪,陈江波,刘为营,等.沸石咪唑类骨架负载黄芩素纳米材料的构建及释药研究[J].天津理工大学学报,2022,38(3):59-64.
2023年第54卷第7期
21
4
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2023.07.009
  • 接收时间:2023-05-10
  • 首发时间:2026-11-19
  • 出版时间:2023-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-05-10
基金
上海市青年科技英才扬帆计划(20YF1404500)
复旦大学附属华山医院科研启动基金项目(2019QD012)
作者信息
    1.复旦大学附属华山医院中西医结合科,上海 200040
    2.复旦大学药学院药剂学系,智能化递药教育部及全军重点实验室(复旦大学),复旦大学中西医结合研究院,上海 201203
    3.上海泰禛生物技术有限公司研发部,上海 201314

通讯作者:

陆伟跃(1960—),男,博士,复旦大学药学院教授、博士生导师,从事药物靶向策略及递药系统研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2023.07.009
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏